Corvus Pharmaceuticals In... (CRVS)
undefined
undefined%
At close: undefined
7.51
2.18%
After-hours Dec 13, 2024, 06:34 PM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14
Net Income -27.03M -41.31M -43.24M -6.00M -46.67M -46.94M -55.66M -36.38M -31.34M -175.64K
Depreciation & Amortization 151.00K 367.00K 460.00K 632.00K 743.00K 847.00K 842.00K 594.00K 148.00K -
Stock-Based Compensation 2.15M 2.69M 4.23M 5.75M 7.35M 7.13M 6.23M 3.83M 428.00K -
Other Working Capital -3.71M 1.08M -827.00K 890.00K 1.45M 33.00K 1.02M 2.93M 592.00K 8.73K
Other Non-Cash Items 4.39M 9.81M 5.07M -37.07M -644.00K -608.00K -195.00K 4.48M 17.64M 62.18K
Deferred Income Tax - - - - - - - -3.83M -41.00K -
Change in Working Capital -3.59M 1.41M -3.24M 1.91M 1.90M -1.42M 2.58M 3.45M 1.83M 8.73K
Operating Cash Flow -23.93M -27.02M -36.72M -34.78M -37.32M -40.99M -46.21M -27.86M -11.33M -104.73K
Capital Expenditures -34.00K -269.00K -5.00K -76.00K -25.00K -355.00K -266.00K -2.20M -1.75M -
Acquisitions - 22.00K -21.57K -44.84K -3.28K - - - - -
Purchase of Investments -47.05M -66.19M -9.36M -42.54M -138.59M -161.86M -88.31M -258.28M -104.39M -
Sales Maturities Of Investments 62.62M 43.16M 30.92M 87.39M 141.87M 132.02M 173.40M 217.92M 14.10M -
Other Investing Acitivies - -23.01K 21.57K 44.84K 3.28K -29.84M 85.09M -40.36M -90.28M -
Investing Cash Flow 15.54M -23.28M 21.56M 44.77M 3.25M -30.19M 84.83M -42.56M -92.03M -
Debt Repayment - - - - - - - - - -
Common Stock Repurchased - - - - - - - - - -
Dividend Paid - - - - - - - - - -
Other Financial Acitivies 12.00K - 1.22M 88.00K 24.00K 393.00K 731.00K 4.00K 94.95M 13.76M
Financial Cash Flow 7.86M - 62.16M 1.31M 24.00K 65.27M 1.44M 71.36M 94.95M 13.76M
Net Cash Flow -539.00K -50.30M 47.00M 11.30M -34.04M -5.91M 40.06M 945.00K -8.41M 13.65M
Free Cash Flow -23.97M -27.29M -36.72M -34.85M -37.35M -41.34M -46.48M -30.06M -13.07M -104.73K